ExlService Holdings, Inc. — Q2 2022 Form 10-Q
Business context and reporting period
Unaudited results cover the three and six months ended June 30, 2022, compared with the same 2021 periods. ExlService provides data analytics and digital operations and solutions, reported through Insurance, Healthcare, Analytics and Emerging Business segments.
Financial performance
- Revenue: Q2 revenue rose 26.1% to $346.8 million; first-half revenue rose 26.0% to $676.0 million. Analytics was the largest growth driver: up 44.8% in Q2 and 45.2% for the first half. Q2 Healthcare revenue fell 18.4%; first-half Healthcare revenue declined 15.9%.
- Profit and margins: Q2 operating income increased 31.4% to $47.1 million, with operating margin rising to 13.6% from 13.0%. Net income increased to $35.8 million from $28.0 million; diluted EPS was $1.06 versus $0.81. Gross margin declined to 36.2% from 37.9%. For the first half, operating income rose to $91.1 million from $77.4 million, while operating margin declined to 13.5% from 14.4%; net income was $72.0 million versus $60.0 million and diluted EPS was $2.13 versus $1.75. Gross margin fell to 36.6% from 38.6%.
- Cash flow and liquidity: First-half operating cash flow was $53.0 million, compared with $53.9 million. Investing activities used $41.0 million, including $25.1 million of capital expenditures; financing activities used $35.3 million. Cash, cash equivalents and restricted cash totaled $115.2 million at June 30. Cash, cash equivalents and short-term investments totaled $265.2 million, including $241.1 million located outside the U.S. Accounts receivable increased to $237.5 million, and days sales outstanding rose to 60 from 58 a year earlier.
- Debt: Borrowings totaled $285.0 million at June 30, comprising $35.0 million current and $250.0 million long-term. In April, the company amended and extended its revolving facility, increasing commitments from $300 million to $400 million and extending maturity to April 2027. The company reported compliance with covenants.
- Capital returns: The company repurchased $57.0 million of shares under its repurchase programs in the first half of 2022.
Material changes and management commentary
- Management attributed most revenue growth to higher Analytics volumes from new and existing clients, supplemented by $11.0 million of Clairvoyant acquisition revenue in Q2 and $21.2 million in the first half. Clairvoyant was acquired in December 2021. The June 2022 Inbound acquisition added digital marketing and insurance lead-generation capabilities; its impact was not material to reported results.
- Higher employee-related costs, wage inflation, incentives and headcount weighed on margins. Management also cited client ramp-up costs in Insurance and Emerging Business and lower Healthcare revenue from ramp-downs at certain clients.
- First-half net income growth did not translate into higher operating cash flow; management cited incentive payments and working-capital movements. The company said it expects 2022 capital expenditures of $40–$45 million and believes available liquidity will meet requirements over the next 12 months. No revenue or earnings guidance is stated in the provided filing text.
Risks, contingencies and unusual items
- Client and geographic concentration remain significant: the top ten clients provided 36.2% of first-half revenue, and U.S. clients provided 85.9%. Contracts may be terminable on short notice; management also notes competitive pricing and alternative pricing models may pressure margins.
- Foreign currency movements generated substantial other comprehensive losses: $35.1 million in Q2 and $43.9 million in the first half, primarily from translation and cash-flow hedge losses. First-half total comprehensive income was $28.1 million versus net income of $72.0 million.
- Contingent consideration liabilities for Clairvoyant and Inbound were valued at $11.4 million at June 30; changes in the Clairvoyant estimate reduced Q2 other income by $1.0 million.
- Indian tax matters include transfer-pricing, corporate-tax and permanent-establishment demands of $29.5 million net of advance payments, plus VAT demands of $5.8 million and rejected GST refund claims of $3.7 million. The company has not accrued provisions for these matters, stating it believes its positions are more likely than not to be sustained. Outcomes and potential losses in pending litigation could not be reasonably estimated.
- Management stated COVID-19 had not significantly affected first-half results, but its future impact remains uncertain. The filing also identifies risks from inflation and global economic and political conditions, including the Russia-Ukraine conflict, cybersecurity, hiring and retention, acquisitions, and goodwill recoverability.
Investor verification priorities
- Assess how much Analytics growth is recurring and organic versus acquisition-related, and monitor whether Healthcare client ramp-downs continue.
- Track gross-margin recovery, particularly the effects of wage inflation, new-client ramp-ups and lower Healthcare utilization.
- Monitor receivables, DSO and operating cash conversion as revenue expands.
- Review foreign-exchange and hedge impacts, including the accumulated hedge losses that may be reclassified into earnings.
- Follow developments in Indian tax disputes and confirm capital-spending, liquidity and debt-facility assumptions against subsequent disclosures.